We are live on ! Find out more
DVAX

Dynavax Technologies

Delisted

DVAX was delisted on the 9th of February, 2026.

111 hedge funds and large institutions have $348M invested in Dynavax Technologies in 2017 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 54 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

307% more call options, than puts

Call options by funds: $36.4M | Put options by funds: $8.95M

145% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 22

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

95% more capital invested

Capital invested by funds: $178M → $348M (+$169M)

10% more funds holding

Funds holding: 101111 (+10)

5.44% more ownership

Funds ownership: 68.28%73.71% (+5.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
111
Holders Change
+10
Holders Change %
+9.9%
% of All Funds
2.77%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
54
Reduced
22
Closed
9
Calls
$36.4M
Puts
$8.95M
Net Calls
+$27.5M
Net Calls Change
+$19.5M
Name Holding Trade Value Shares
Change
Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$644K +$137K +21,100 +46%
Wells Fargo
52
Wells Fargo
California
$605K +$136K +20,900 +50%
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$584K +$103K +15,865 +36%
Wolverine Trading
54
Wolverine Trading
Illinois
$582K +$220K +33,894 +139%
ECM
55
Endurant Capital Management
California
$578K -$738K -113,600 -65%
New York State Common Retirement Fund
56
New York State Common Retirement Fund
New York
$506K +$77.3K +11,899 +29%
Invesco
57
Invesco
Georgia
$504K +$5.84K +899 +2%
CS
58
Credit Suisse
Switzerland
$452K +$80.7K +12,423 +36%
Goldman Sachs
59
Goldman Sachs
New York
$429K -$74.1K -11,415 -20%
MFM
60
MHR Fund Management
New York
$429K
VKH
61
Virtu KCG Holdings
New York
$419K -$157K -24,192 -36%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$399K +$52.5K +8,092 +24%
VEA
63
Virtus ETF Advisers
New York
$368K +$248K +38,177 New
UBS Group
64
UBS Group
Switzerland
$361K +$221K +34,088 +1,035%
T. Rowe Price Associates
65
T. Rowe Price Associates
Maryland
$348K -$1.78K -274 -0.8%
MLICM
66
Metropolitan Life Insurance Company (MetLife)
New York
$342K +$230K +35,416 New
State of Wisconsin Investment Board
67
State of Wisconsin Investment Board
Wisconsin
$328K +$221K +34,000 New
PPA
68
Parametric Portfolio Associates
Washington
$297K +$23.4K +3,604 +13%
FO
69
FT Options
Illinois
$297K +$200K +30,795 New
AIG
70
American International Group
New York
$294K +$42.3K +6,519 +27%
NFA
71
Nationwide Fund Advisors
Ohio
$274K +$4.49K +692 +3%
Mariner
72
Mariner
Kansas
$273K
Barclays
73
Barclays
United Kingdom
$211K +$136K +21,005 +2,406%
ST
74
Spot Trading
Illinois
$208K +$117K +18,025 +515%
VOYA Investment Management
75
VOYA Investment Management
Georgia
$207K +$29K +4,462 +26%

DVAX Hedge Fund Activity: Q2 2017 in Review

111 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Dynavax Technologies (DVAX) for Q2 2017, worth a combined $348M — up 95% from $178M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new DVAX positions and 9 closed out — a net gain of 11 holders — while 54 added to existing stakes and 22 trimmed.

The largest buyer was PointState Capital, opening a new position worth an estimated $9.09M. The largest seller was Redmile Group, exiting entirely with an estimated $6.07M sold.

  • 111 institutional investors held Dynavax Technologies (DVAX) as of Q2 2017, up from 101 in Q1 2017.
  • Funds reported $348M of Dynavax Technologies stock for Q2 2017, up 95% quarter-over-quarter.
  • 20 funds opened new Dynavax Technologies positions in Q2 2017 and 9 closed out, a net change of +11 holders.
  • The largest Dynavax Technologies buyer in Q2 2017 was PointState Capital, an estimated $9.09M added.
  • The largest Dynavax Technologies seller in Q2 2017 was Redmile Group, an estimated $6.07M sold.

Based on aggregated 13F filings for Q2 2017.